Data for: The JNK inhibitor AS602801 Synergizes with Enzalutamide to kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression

Name: Data for: The JNK inhibitor AS602801 Synergizes with Enzalutamide to kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression
Creator: Carlos Moreno
Published: 2020-03-18T22:16:34.456Z
Keywords: Gene Expression

Moreno, Carlos; Osunkoya, Adeboye; Sun, Carrie; Li, Zhenghong; Zu, Xiongbing; Tao, Sijia; Petros, John; Arnold, Rebecca

doi:10.17632/zpyh5ybtkj.1

Data for: The JNK inhibitor AS602801 Synergizes with Enzalutamide to kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression

Published: 18 March 2020| Version 1 | DOI: 10.17632/zpyh5ybtkj.1

Contributors:

Carlos Moreno, Adeboye Osunkoya, Carrie Sun, Zhenghong Li, Xiongbing Zu, Sijia Tao, John Petros, Rebecca Arnold

Description

Nanostring data from pancancer panel analysis of LNCaP cells treated with AS602801, Enzalutamide, or both.

Data for: The JNK inhibitor AS602801 Synergizes with Enzalutamide to kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression

Description

Files

Categories

Licence